{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:24:39Z","timestamp":1788780279535,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Natural Science Foundation of Beijing Municipality (CN)","award":["7194307"],"award-info":[{"award-number":["7194307"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81501414"],"award-info":[{"award-number":["81501414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2016YFA010100"],"award-info":[{"award-number":["2016YFA010100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10620-021-07165-1","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T17:02:33Z","timestamp":1628960553000},"page":"2981-2993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Downregulation of Programmed Death-1 Pathway Promoting CD8\u2009+\u2009T Cell Cytotoxicity in Primary Biliary Cholangitis"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8171-2779","authenticated-orcid":false,"given":"Shuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tihong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,14]]},"reference":[{"key":"7165_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570\u20131580.","journal-title":"N Engl J Med."},{"key":"7165_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","volume":"52","author":"R Poupon","year":"2010","unstructured":"Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010;52:745\u2013758.","journal-title":"J Hepatol."},{"key":"7165_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","volume":"8","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol. 2013;8:303\u2013330.","journal-title":"Annu Rev Pathol."},{"key":"7165_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181\u20131188.","journal-title":"J Hepatol."},{"key":"7165_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1055\/s-0034-1383730","volume":"34","author":"L Griffiths","year":"2014","unstructured":"Griffiths L, Dyson JK, Jones DE. The new epidemiology of primary biliary cirrhosis. Semin Liver Dis. 2014;34:318\u2013328.","journal-title":"Semin Liver Dis."},{"key":"7165_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1471-230X-10-100","volume":"10","author":"H Liu","year":"2010","unstructured":"Liu H, Liu Y, Wang L et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol. 2010;10:100.","journal-title":"BMC Gastroenterol."},{"key":"7165_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C, Carrat F, Bahr A, Chr\u00e9tien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005;128:297\u2013303.","journal-title":"Gastroenterology."},{"key":"7165_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/JCI0214698","volume":"109","author":"H Kita","year":"2002","unstructured":"Kita H, Matsumura S, He XS et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest. 2002;109:1231\u20131240.","journal-title":"J Clin Invest."},{"key":"7165_CR9","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4049\/jimmunol.1001597","volume":"186","author":"GX Yang","year":"2011","unstructured":"Yang GX, Wu Y, Tsukamoto H et al. CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease. J Immunol. 2011;186:1259\u20131267.","journal-title":"J Immunol."},{"key":"7165_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677\u2013704.","journal-title":"Annu Rev Immunol."},{"key":"7165_CR11","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.18632\/oncotarget.2980","volume":"6","author":"JJ Luke","year":"2015","unstructured":"Luke JJ, Ott PA. PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma. Oncotarget. 2015;6:3479\u20133492.","journal-title":"Oncotarget."},{"key":"7165_CR12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/OTT.S48443","volume":"7","author":"SS Tykodi","year":"2014","unstructured":"Tykodi SS. PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence. Onco Targets Ther. 2014;7:1349\u20131359.","journal-title":"Onco Targets Ther."},{"key":"7165_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8:239\u2013245.","journal-title":"Nat Immunol."},{"key":"7165_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1572-0241.2006.00948.x","volume":"102","author":"N Mataki","year":"2007","unstructured":"Mataki N, Kikuchi K, Kawai T et al. Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. Am J Gastroenterol. 2007;102:302\u2013312.","journal-title":"Am J Gastroenterol."},{"key":"7165_CR15","doi-asserted-by":"publisher","first-page":"28588","DOI":"10.18632\/oncotarget.5665","volume":"6","author":"AR Concepcion","year":"2015","unstructured":"Concepcion AR, Salas JT, S\u00e1ez E et al. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a, b-\/- mice favoring autoimmune cholangitis. Oncotarget. 2015;6:28588\u201328606.","journal-title":"Oncotarget."},{"key":"7165_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492\u2013499.","journal-title":"Nat Immunol."},{"key":"7165_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fimmu.2015.00310","volume":"6","author":"SA Fuertes Marraco","year":"2015","unstructured":"Fuertes Marraco SA, Neubert NJ, Verdeil G, Speiser DE. Inhibitory receptors beyond T Cell exhaustion. Front Immunol. 2015;6:310.","journal-title":"Front Immunol."},{"key":"7165_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2016.01.018","volume":"44","author":"A Taylor","year":"2016","unstructured":"Taylor A, Harker JA, Chanthong K, Stevenson PG, Zuniga EI, Rudd CE. Glycogen synthase kinase 3 inactivation drives T-bet-mediated downregulation of co-receptor PD-1 to enhance CD8(+) cytolytic T Cell responses. Immunity. 2016;44:274\u2013286.","journal-title":"Immunity."},{"key":"7165_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology."},{"key":"7165_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978;379:103\u2013112.","journal-title":"Virchows Arch A Pathol Anat Histol."},{"key":"7165_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","volume":"310","author":"MR Zamani","year":"2016","unstructured":"Zamani MR, Aslani S, Salmaninejad A, Javan MR, Rezaei N. PD-1\/PD-L and autoimmunity: a growing relationship. Cell Immunol. 2016;310:27\u201341.","journal-title":"Cell Immunol."},{"key":"7165_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48:871\u2013877.","journal-title":"Hepatology."},{"key":"7165_CR23","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/art.27417","volume":"62","author":"H Kristjansdottir","year":"2010","unstructured":"Kristjansdottir H, Steinsson K, Gunnarsson I, Gr\u00f6ndal G, Erlendsson K, Alarc\u00f3n-Riquelme ME. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus. Arthritis Rheum 2010;62:1702\u20131711.","journal-title":"Arthritis Rheum"},{"key":"7165_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10753-013-9718-8","volume":"37","author":"S Li","year":"2014","unstructured":"Li S, Liao W, Chen M et al. Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis. Inflammation. 2014;37:116\u2013121.","journal-title":"Inflammation."},{"key":"7165_CR25","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","volume":"134","author":"JT Salas","year":"2008","unstructured":"Salas JT, Banales JM, Sarvide S et al. Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology. 2008;134:1482\u20131493.","journal-title":"Gastroenterology."},{"key":"7165_CR26","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.4049\/jimmunol.0900080","volume":"182","author":"S Chikuma","year":"2009","unstructured":"Chikuma S, Terawaki S, Hayashi T et al. PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. J Immunol. 2009;182:6682\u20136689.","journal-title":"J Immunol."},{"key":"7165_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/eji.201343658","volume":"44","author":"C McBerry","year":"2014","unstructured":"McBerry C, Dias A, Shryock N et al. PD-1 modulates steady-state and infection-induced IL-10 production in vivo. Eur J Immunol. 2014;44:469\u2013479.","journal-title":"Eur J Immunol."},{"key":"7165_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/0891693021000056703","volume":"35","author":"M Matsushita","year":"2002","unstructured":"Matsushita M, Tanaka A, Kikuchi K et al. Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients. Autoimmunity. 2002;35:531\u2013536.","journal-title":"Autoimmunity."},{"key":"7165_CR29","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192:1027\u20131034.","journal-title":"J Exp Med."},{"key":"7165_CR30","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1158\/2159-8290.CD-15-1347","volume":"6","author":"BV Park","year":"2016","unstructured":"Park BV, Freeman ZT, Ghasemzadeh A et al. TGF\u03b21-Mediated SMAD3 enhances PD-1 expression on antigen-specific T Cells in cancer. Cancer Discov. 2016;6:1366\u20131381.","journal-title":"Cancer Discov."},{"key":"7165_CR31","first-page":"728","volume":"4","author":"M Santarpia","year":"2015","unstructured":"Santarpia M, Gonz\u00e1lez-Cao M, Viteri S, Karachaliou N, Altavilla G, Rosell R. Programmed cell death protein-1\/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role. Transl Lung Cancer Res. 2015;4:728\u2013742.","journal-title":"Transl Lung Cancer Res."},{"key":"7165_CR32","first-page":"451694","volume":"201","author":"KA Hofmeyer","year":"2011","unstructured":"Hofmeyer KA, Jeon H, Zang X. The PD-1\/PD-L1 (B7\u2013H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion. J Biomed Biotechnol 2011;201:451694.","journal-title":"J Biomed Biotechnol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07165-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T19:36:16Z","timestamp":1656358576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,14]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7165"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07165-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,14]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Research Ethics Committee of Peking Union Medical College Hospital (No. S-283).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from each patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}